Cargando…
Possible Serological Markers to Predict Mortality in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Background and objectives: Idiopathic pulmonary fibrosis (IPF) has a particularly poor prognosis, and most IPF-related deaths are due to acute exacerbation (AE) of this condition. Few reports about biomarkers to predict prognosis of AE-IPF have been published since the release of the new AE-IPF crit...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6571816/ https://www.ncbi.nlm.nih.gov/pubmed/31086028 http://dx.doi.org/10.3390/medicina55050132 |
_version_ | 1783427497020358656 |
---|---|
author | Hachisu, Yoshimasa Murata, Keisuke Takei, Kousuke Tsuchiya, Takuma Tsurumaki, Hiroaki Koga, Yasuhiko Horie, Takeo Takise, Atsushi Hisada, Takeshi |
author_facet | Hachisu, Yoshimasa Murata, Keisuke Takei, Kousuke Tsuchiya, Takuma Tsurumaki, Hiroaki Koga, Yasuhiko Horie, Takeo Takise, Atsushi Hisada, Takeshi |
author_sort | Hachisu, Yoshimasa |
collection | PubMed |
description | Background and objectives: Idiopathic pulmonary fibrosis (IPF) has a particularly poor prognosis, and most IPF-related deaths are due to acute exacerbation (AE) of this condition. Few reports about biomarkers to predict prognosis of AE-IPF have been published since the release of the new AE-IPF criteria in 2016. The present study investigated relationships between serological markers and in-hospital mortality after the onset of AE-IPF. Methods: Demographic, serological, and imaging data from patients hospitalized at the Maebashi Red Cross Hospital (Gunma, Japan) between 1 January 2013, and 31 December 2017, were retrospectively reviewed. Subjects fulfilling the diagnostic criteria for AE-IPF were divided into those who survived or died; statistical analysis of risk factors was performed using data from these two groups. Results: Diagnostic criteria for AE-IPF were fulfilled by 84 patients (59 males (70.2%)), with a median age of 78 years (range, 56–95 years). IPF was diagnosed before hospitalization in 50 (59.5%) patients and 38 (45.2%) died in hospital. Among the serological markers at hospitalization in the deceased group, C-reactive protein (CRP) was significantly higher than in the survivor group (p = 0.002), while total serum protein (p = 0.031), albumin (p = 0.047) and total cholesterol (p = 0.039) were significantly lower. Cox hazard analysis of factors predicting mortality, corrected for age, sex and BMI, revealed the following: CRP (hazard ratio (HR) 1.080 (95% confidence interval (CI) 1.022–1.141); p = 0.006), LDH (HR 1.003 (95% CI 1.000–1.006); p = 0.037), and total cholesterol (HR 0.985 (95% CI 0.972–0.997); p = 0.018). Conclusions: Our data suggest that CRP, LDH, and total cholesterol may be biomarkers predicting mortality in patients with AE-IPF. However, only prospective controlled studies can confirm or not our observation as a generalizable one. |
format | Online Article Text |
id | pubmed-6571816 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-65718162019-06-18 Possible Serological Markers to Predict Mortality in Acute Exacerbation of Idiopathic Pulmonary Fibrosis Hachisu, Yoshimasa Murata, Keisuke Takei, Kousuke Tsuchiya, Takuma Tsurumaki, Hiroaki Koga, Yasuhiko Horie, Takeo Takise, Atsushi Hisada, Takeshi Medicina (Kaunas) Article Background and objectives: Idiopathic pulmonary fibrosis (IPF) has a particularly poor prognosis, and most IPF-related deaths are due to acute exacerbation (AE) of this condition. Few reports about biomarkers to predict prognosis of AE-IPF have been published since the release of the new AE-IPF criteria in 2016. The present study investigated relationships between serological markers and in-hospital mortality after the onset of AE-IPF. Methods: Demographic, serological, and imaging data from patients hospitalized at the Maebashi Red Cross Hospital (Gunma, Japan) between 1 January 2013, and 31 December 2017, were retrospectively reviewed. Subjects fulfilling the diagnostic criteria for AE-IPF were divided into those who survived or died; statistical analysis of risk factors was performed using data from these two groups. Results: Diagnostic criteria for AE-IPF were fulfilled by 84 patients (59 males (70.2%)), with a median age of 78 years (range, 56–95 years). IPF was diagnosed before hospitalization in 50 (59.5%) patients and 38 (45.2%) died in hospital. Among the serological markers at hospitalization in the deceased group, C-reactive protein (CRP) was significantly higher than in the survivor group (p = 0.002), while total serum protein (p = 0.031), albumin (p = 0.047) and total cholesterol (p = 0.039) were significantly lower. Cox hazard analysis of factors predicting mortality, corrected for age, sex and BMI, revealed the following: CRP (hazard ratio (HR) 1.080 (95% confidence interval (CI) 1.022–1.141); p = 0.006), LDH (HR 1.003 (95% CI 1.000–1.006); p = 0.037), and total cholesterol (HR 0.985 (95% CI 0.972–0.997); p = 0.018). Conclusions: Our data suggest that CRP, LDH, and total cholesterol may be biomarkers predicting mortality in patients with AE-IPF. However, only prospective controlled studies can confirm or not our observation as a generalizable one. MDPI 2019-05-13 /pmc/articles/PMC6571816/ /pubmed/31086028 http://dx.doi.org/10.3390/medicina55050132 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Hachisu, Yoshimasa Murata, Keisuke Takei, Kousuke Tsuchiya, Takuma Tsurumaki, Hiroaki Koga, Yasuhiko Horie, Takeo Takise, Atsushi Hisada, Takeshi Possible Serological Markers to Predict Mortality in Acute Exacerbation of Idiopathic Pulmonary Fibrosis |
title | Possible Serological Markers to Predict Mortality in Acute Exacerbation of Idiopathic Pulmonary Fibrosis |
title_full | Possible Serological Markers to Predict Mortality in Acute Exacerbation of Idiopathic Pulmonary Fibrosis |
title_fullStr | Possible Serological Markers to Predict Mortality in Acute Exacerbation of Idiopathic Pulmonary Fibrosis |
title_full_unstemmed | Possible Serological Markers to Predict Mortality in Acute Exacerbation of Idiopathic Pulmonary Fibrosis |
title_short | Possible Serological Markers to Predict Mortality in Acute Exacerbation of Idiopathic Pulmonary Fibrosis |
title_sort | possible serological markers to predict mortality in acute exacerbation of idiopathic pulmonary fibrosis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6571816/ https://www.ncbi.nlm.nih.gov/pubmed/31086028 http://dx.doi.org/10.3390/medicina55050132 |
work_keys_str_mv | AT hachisuyoshimasa possibleserologicalmarkerstopredictmortalityinacuteexacerbationofidiopathicpulmonaryfibrosis AT muratakeisuke possibleserologicalmarkerstopredictmortalityinacuteexacerbationofidiopathicpulmonaryfibrosis AT takeikousuke possibleserologicalmarkerstopredictmortalityinacuteexacerbationofidiopathicpulmonaryfibrosis AT tsuchiyatakuma possibleserologicalmarkerstopredictmortalityinacuteexacerbationofidiopathicpulmonaryfibrosis AT tsurumakihiroaki possibleserologicalmarkerstopredictmortalityinacuteexacerbationofidiopathicpulmonaryfibrosis AT kogayasuhiko possibleserologicalmarkerstopredictmortalityinacuteexacerbationofidiopathicpulmonaryfibrosis AT horietakeo possibleserologicalmarkerstopredictmortalityinacuteexacerbationofidiopathicpulmonaryfibrosis AT takiseatsushi possibleserologicalmarkerstopredictmortalityinacuteexacerbationofidiopathicpulmonaryfibrosis AT hisadatakeshi possibleserologicalmarkerstopredictmortalityinacuteexacerbationofidiopathicpulmonaryfibrosis |